Continuous infusion of piperacillin and therapeutic drug monitoring for treatment of critically ill patients

被引：0
|
作者：
Koeberer, A. [1 ]
Frey, O. R. [2 ]
Papadimas, N. [3 ]
Fuchs, T. [1 ]
Roehr, A. [2 ]
Brinkmann, A. [1 ]
机构：
[1] Gen Hosp Heidenheim, Dept Anesthesiol & Intens Care Med, Heidenheim, Germany
[2] Gen Hosp Heidenheim, Dept Pharm, Heidenheim, Germany
[3] Gen Hosp Heidenheim, Dept Urol, Heidenheim, Germany
来源：
INFECTION | 2013年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
059
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] Continuous infusion of meropenem and therapeutic drug monitoring for treatment of critically ill patients
    Koeberer, A.
    Frey, O. R.
    Fuchs, T.
    Roehr, A.
    Brinkmann, A.
    [J]. INFECTION, 2013, 41 : S53 - S54
  • [2] Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients
    Dhaese, Sofie A. M.
    Roberts, Jason A.
    Carlier, Mieke
    Verstraete, Alain G.
    Stove, Veronique
    DeWaele, Jan J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (04) : 594 - 600
  • [3] Neurotoxic Concentration of Piperacillin during Continuous Infusion in Critically Ill Patients
    Quinton, Marie-Charlotte
    Bodeau, Sandra
    Kontar, Loay
    Zerbib, Yoann
    Maizel, Julien
    Slama, Michel
    Masmoudi, Kamel
    Lemaire-Hurtel, Anne-Sophie
    Bennis, Youssef
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (09)
  • [4] Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion
    Dhaese, S. A. M.
    Colin, P.
    Willems, H.
    Heffernan, A.
    Gadeyne, B.
    Van Vooren, S.
    Depuydt, P.
    Hoste, E.
    Stove, V
    Verstraete, A. G.
    Lipman, J.
    Roberts, J. A.
    De Waele, J. J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (06) : 741 - 749
  • [5] Is therapeutic drug monitoring really helpful for managing piperacillin/tazobactam therapy in critically ill patients?
    Novy, Emmanuel
    Francois, Thomas
    Luc, Amandine
    Pape, Elise
    Scala-Bertola, Julien
    [J]. INTENSIVE CARE MEDICINE, 2022, 48 (11) : 1676 - 1678
  • [6] Is therapeutic drug monitoring really helpful for managing piperacillin/tazobactam therapy in critically ill patients?
    Emmanuel Novy
    Thomas François
    Amandine Luc
    Elise Pape
    Julien Scala-Bertola
    [J]. Intensive Care Medicine, 2022, 48 : 1676 - 1678
  • [7] Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020
    Drager, Sarah
    von Rotz, Matthias
    Labhardt, Niklaus D.
    Siegemund, Martin
    Rentsch, Katharina M.
    Osthoff, Michael
    Franzeck, Fabian C.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [8] Therapeutic drug monitoring-guided piperacillin dosing in critically ill patients undergoing continuous renal replacement therapy: a systematic review
    Rozi, Nazatul Adhwa Mohd
    Tahir, Nor Asyikin Mohd
    Saffian, Shamin Mohd
    Makmor-Bakry, Mohd
    Yusof, Aliza Mohamad
    Mustafar, Ruslinda
    Saud, Muhammad Nordin
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024,
  • [9] Therapeutic Drug Monitoring of Phenytoin in Critically Ill Patients
    von Winckelmann, Sandrina L.
    Spriet, Isabel
    Willems, Ludo
    [J]. PHARMACOTHERAPY, 2008, 28 (11): : 1391 - 1400
  • [10] β-Lactam Therapeutic Drug Monitoring in Critically Ill Patients
    Zeggil, Teagan
    Dalton, Bruce
    [J]. CLINICAL INFECTIOUS DISEASES, 2023, 76 (12) : 2212 - 2213
12345